Healthcare -
Drug Manufacturers - General - NASDAQ - US
$ 116.6
2 %
$ 145 B
Market Cap
25.29
P/E
GILD - REVENUE
Revenue GILD - Gilead Sciences, Inc.
28.8 B
LAST VALUE
2.66%
2 YEAR CAGR
5.08%
5 YEAR CAGR
1.45%
10 YEAR CAGR